Todd Alfred Carter, Chief Scientific Officer: Voyager Therapeutics VYGR Planned sale · Filed 02/18

Trade details

Type: Planned sale notice
Stock: Voyager Therapeutics VYGR
Person: Todd Alfred CarterChief Scientific Officer
Planned sale date: 26/02/18
Filed: 26/02/18

More to sell after $13.6K in 3 months

Voyager Therapeutics trades, last 26 weeks

What else happened in Voyager Therapeutics around then

Filed or reported within 30 days of the trade day · 01/19~03/20

Todd Alfred Carter's recent trades

Todd Alfred CarterChief Scientific Officer
Sell10b5-1 planVoyager Therapeutics
Sell10b5-1 plan
Voyager Therapeutics
VYGR
$15.7K
4,174 sh
$15.7K
Filed 02/26
Traded 02/24
Todd Alfred CarterChief Scientific Officer
Planned saleVoyager Therapeutics
Planned sale
Voyager Therapeutics
VYGR
$15.7K
4,174 sh
$15.7K
Filed 02/24
Traded 02/24
Todd Alfred CarterChief Scientific Officer
Sell10b5-1 planVoyager Therapeutics
Sell10b5-1 plan
Voyager Therapeutics
VYGR
$11.4K
3,301 sh
$11.4K
Filed 02/20
Traded 02/18
Todd Alfred CarterChief Scientific Officer
SellVoyager Therapeutics
Sell
Voyager Therapeutics
VYGR
$13.6K
3,525 sh
$13.6K
Filed 02/11
Traded 02/10
Todd Alfred CarterChief Scientific Officer
Planned saleVoyager Therapeutics
Planned sale
Voyager Therapeutics
VYGR
$13.6K
3,525 sh
$13.6K
Filed 02/10
Traded 02/10

Todd Alfred Carter, Chief Officer — plans to sell 3,301 sh of Voyager Therapeutics VYGR · $11.3K · around 02/18 | Whalegun